+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acorda Therapeutics Inc - logo

Acorda Therapeutics is a biopharmaceutical company that identifies, develops, and commercializes novel therapies for neurological disorders in the United States. It specializes in drugs that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Its best known products are Zanaflex, Ampyra and Qutenza. Acorda Therapeutics was founded in 1995 and is headquartered in Ardsley, New York.

From
Global Krabbe Disease Treatment Market 2022-2026 - Product Thumbnail Image

Global Krabbe Disease Treatment Market 2022-2026

  • Report
  • April 2022
  • 120 Pages
From
From
Anti-Parkinson's Drugs: Global Markets to 2022 - Product Thumbnail Image

Anti-Parkinson's Drugs: Global Markets to 2022

  • Report
  • March 2018
  • 172 Pages
From
From
Bladder Pain - Pipeline Insight, 2020 - Product Thumbnail Image

Bladder Pain - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
From
From
Migraine (Central Nervous System) - Drugs in Development, 2021 - Product Thumbnail Image

Migraine (Central Nervous System) - Drugs in Development, 2021

  • Drug Pipelines
  • September 2021
  • 363 Pages
From
From
From
Cerebral Palsy - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Cerebral Palsy - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 198 Pages
From
From
Loading Indicator